Influence of Immunogenicity on the Long-Term Efficacy of Infliximab in Crohn's Disease

Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factor ? monoclonal antibody combined with low-dose weekly methotrexate in rheumatoid arthritis

1998 • 1,642 citations

INFLIXIMAB AND METHOTREXATE IN THE TREATMENT OF RHEUMATOID ARTHRITIS

2000 • 1,181 citations

Efficacy and safety of retreatment with anti–tumor necrosis factor antibody (infliximab) to maintain remission in Crohn's disease

1999 • 1,107 citations

Therapeutic monoclonal antibodies

2000 • 337 citations

Infliximab for Crohn's disease in clinical practice at the Mayo Clinic: the first 100 patients

2001 • 296 citations

Antibody humanization: a case of the ‘Emperor’s new clothes’?

2000 • 252 citations

Infliximab in Crohn's Disease: First Anniversary Clinical Experience

2000 • 238 citations

Clinical Experience With Infliximab Therapy in 100 Patients With Crohn's Disease

2000 • 215 citations

Review article: safety of infliximab in clinical trials

1999 • 173 citations

Pharmacokinetic Considerations in the Treatment of Inflammatory Bowel Disease

2001 • 131 citations

Humanized Antibodies as Potential Therapeutic Drugs

1998 • 59 citations

Efficacy and safety of repeated infliximab infusions for Crohn's disease: 1-year clinical experience

2001 • 54 citations

Safety of infliximab in clinical trials

1999 • 37 citations

Human anti-chimeric antibody levels correlate with lack of response and infusion reactions following infliximab therapy

2001 • 24 citations

Allogeneic transplantation of blood stem cells: Coming of age?

2001 • 12 citations

The future of monoclonal antibody engineering

2001 • 8 citations

Targetted gene deletion of murine SP/TTF2 results in decreased gastric proliferation, increased basal acid secretion and increased susceptibility to NSAID injury

2001 • 1 citations

Cited By (0)

No citing papers found in database